These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17784787)

  • 1. In vitro and in vivo neurotoxicity of prion protein oligomers.
    Simoneau S; Rezaei H; Salès N; Kaiser-Schulz G; Lefebvre-Roque M; Vidal C; Fournier JG; Comte J; Wopfner F; Grosclaude J; Schätzl H; Lasmézas CI
    PLoS Pathog; 2007 Aug; 3(8):e125. PubMed ID: 17784787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
    Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity of the putative transmembrane domain of the prion protein.
    Haïk S; Peyrin JM; Lins L; Rosseneu MY; Brasseur R; Langeveld JP; Tagliavini F; Deslys JP; Lasmézas C; Dormont D
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):644-56. PubMed ID: 11114262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein misfolding cyclic amplification induces the conversion of recombinant prion protein to PrP oligomers causing neuronal apoptosis.
    Yuan Z; Yang L; Chen B; Zhu T; Hassan MF; Yin X; Zhou X; Zhao D
    J Neurochem; 2015 Jun; 133(5):722-9. PubMed ID: 25810062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
    Uppington KM; Brown DR
    J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases.
    Tayebi M; Hawke S
    Immunol Lett; 2006 Jun; 105(2):123-6. PubMed ID: 16621033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
    Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
    J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicle permeabilization by purified soluble oligomers of prion protein: a comparative study of the interaction of oligomers and monomers with lipid membranes.
    Chich JF; Chapuis C; Henry C; Vidic J; Rezaei H; Noinville S
    J Mol Biol; 2010 Apr; 397(4):1017-30. PubMed ID: 20156446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
    Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
    Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
    Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ
    Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different structural stability and toxicity of PrP(ARR) and PrP(ARQ) sheep prion protein variants.
    Paludi D; Thellung S; Chiovitti K; Corsaro A; Villa V; Russo C; Ianieri A; Bertsch U; Kretzschmar HA; Aceto A; Florio T
    J Neurochem; 2007 Dec; 103(6):2291-300. PubMed ID: 17919292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly neurotoxic monomeric α-helical prion protein.
    Zhou M; Ottenberg G; Sferrazza GF; Lasmézas CI
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3113-8. PubMed ID: 22323583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective and neurotoxic signaling by the prion protein.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Top Curr Chem; 2011; 305():101-19. PubMed ID: 21598098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity.
    White AR; Collins SJ; Maher F; Jobling MF; Stewart LR; Thyer JM; Beyreuther K; Masters CL; Cappai R
    Am J Pathol; 1999 Nov; 155(5):1723-30. PubMed ID: 10550328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax deletion does not protect neurons from BSE-induced death.
    Coulpier M; Messiaen S; Hamel R; Fernández de Marco M; Lilin T; Eloit M
    Neurobiol Dis; 2006 Sep; 23(3):603-11. PubMed ID: 16854590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.
    Gavín R; Ureña J; Rangel A; Pastrana MA; Requena JR; Soriano E; Aguzzi A; Del Río JA
    Neurobiol Dis; 2008 May; 30(2):243-54. PubMed ID: 18374587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell models of prion infection.
    Vilette D
    Vet Res; 2008; 39(4):10. PubMed ID: 18073097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The truncated 23-230 form of the prion protein localizes to the nuclei of inducible cell lines independently of its nuclear localization signals and is not cytotoxic.
    Crozet C; Vézilier J; Delfieu V; Nishimura T; Onodera T; Casanova D; Lehmann S; Béranger F
    Mol Cell Neurosci; 2006 Aug; 32(4):315-23. PubMed ID: 16806967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.